スマートインスリンペンの市場規模、シェア、成長分析、タイプ別、ユーザビリティ別、製品別、接続タイプ別、適応症別、エンドユーザー別、地域別 - 産業予測 2025～2032年

スマートインスリンペン市場規模は2023年に45億米ドルと評価され、2024年の49億6,000万米ドルから2032年には108億7,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは10.3％で成長する見通しです。

スマートインスリンペン市場は、効果的な糖尿病管理ソリューションに対する需要の高まりによって力強い成長を遂げています。これらの革新的なデバイスは、タイムリーなリマインダーやアラートを提供することによって糖尿病患者のインスリン投与を強化し、一貫した投与を保証します。既存のインスリン・ペンとの互換性が、その魅力と使いやすさに拍車をかけています。投与漏れの監視と包括的な糖尿病プロファイルの維持を容易にすることで、これらのペンは1型糖尿病と2型糖尿病の両方を管理するために非常に貴重です。さらに、温度範囲と有効期限をモニターすることで、インスリンの安全な取り扱いを保証します。しかし、COVID-19の大流行が課題となり、必要な糖尿病サービスへのアクセスが制限され、糖尿病プロファイルが管理されない結果となりました。全体として、スマートインスリンペンは糖尿病ケアに便利で効率的なアプローチを提供しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

スマートインスリンペン市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 第一世代のペン
• 第二世代のペン

スマートインスリンペン市場規模：ユーザビリティ別& CAGR（2025-2032）

• 市場概要
• 事前入力済み
• 再利用可能

スマートインスリンペン市場規模：製品別& CAGR（2025-2032）

• 市場概要
• スマートインスリンペン
• 従来型ペン用アダプター

スマートインスリンペン市場規模：接続タイプ別& CAGR（2025-2032）

• 市場概要
• Bluetooth
• USB

スマートインスリンペン市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• 1型糖尿病
• 2型糖尿病

スマートインスリンペン市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院と診療所
• 外来手術センター
• ホームケア設定

スマートインスリンペン市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（USA）
• Medtronic plc（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Ypsomed Holding AG（Switzerland）
• Companion Medical（USA）
• Digital Medics Pty Ltd（Australia）
• Biocorp（France）
• Emperra GmbH（USA）
• E-Health Technologies（Germany）
• Bigfoot Biomedical, Inc.（USA）
• Hoffmann-La Roche AG（Switzerland）
• Tandem Diabetes Care, Inc.（USA）
• Insulet Corporation（USA）
• Abbott Laboratories（USA）
• Terumo Corporation（Japan）
• Owen Mumford Ltd.（UK）
• SOOIL Development Co., Ltd.（South Korea）
• Pendiq GmbH（Germany）
• DarioHealth Corp.（Israel）

結論と提言

Smart Insulin Pens Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.96 billion in 2024 to USD 10.87 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The smart insulin pen market is experiencing robust growth driven by the increasing demand for effective diabetes management solutions. These innovative devices enhance insulin administration for diabetic patients by providing timely reminders and alerts, ensuring consistent dosing. Their compatibility with existing insulin pens adds to their appeal and ease of use. By facilitating the monitoring of missed doses and maintaining a comprehensive diabetes profile, these pens are invaluable for managing both type 1 and type 2 diabetes. Additionally, they ensure the safe handling of insulin by monitoring temperature ranges and expiration dates. However, the COVID-19 pandemic posed challenges, restricting access to necessary diabetic services and resulting in unmanaged diabetes profiles. Overall, smart insulin pens offer a convenient and efficient approach to diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Insulin Pens Market Segments Analysis

Global Smart Insulin Pens Market is segmented by Type, Usability, Product, Connectivity Type, Indication, End User and region. Based on Type, the market is segmented into First Generation Pens and Second Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on Product, the market is segmented into Smart Insulin Pen and Adaptors for Conventional Pen. Based on Connectivity Type, the market is segmented into Bluetooth and USB. Based on Indication, the market is segmented into Type 1diabetesand Type 2 Diabetes. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Insulin Pens Market

The surge in the diabetic population, driven by modern lifestyles and increased demands on the younger generation, has significantly accelerated the market for insulin products. Among these, smart insulin pens have gained considerable traction in recent years. As individuals grapple with the challenges of managing diabetes amidst hectic schedules, traditional methods of tracking glucose levels and insulin dosing become increasingly cumbersome. Smart technology offers a practical solution to these challenges, enhancing convenience and accuracy. Furthermore, the rising prevalence of needle stick injuries has further amplified the appeal of smart insulin pens, prompting manufacturers to ramp up production to capture growing demand and boost revenues in the upcoming years.

Restraints in the Smart Insulin Pens Market

The elevated price point of smart insulin pens could negatively impact their demand worldwide. In developing regions, particularly in Africa, inadequate healthcare systems and unfavorable reimbursement policies deter patients from pursuing necessary treatments and utilizing advanced devices like smart insulin pens. This financial barrier not only limits access to these innovative tools but also exacerbates existing health disparities, as individuals in these areas struggle to receive proper diabetes management solutions. Consequently, the high costs associated with these devices pose a significant challenge to their widespread adoption, particularly in underserved markets where the need for effective diabetes management is critical.

Market Trends of the Smart Insulin Pens Market

The smart insulin pens market is experiencing significant growth driven by advancements in healthcare technology and a rising global diabetic population. Innovative research and development initiatives are facilitating the creation of more sophisticated devices, enhancing patient engagement and management of diabetes. As market manufacturers introduce cutting-edge products that address the unique needs of insulin users, the landscape is evolving to offer greater convenience and accuracy in diabetes care. Moreover, the increasing adoption of digital health solutions and smart connectivity features in insulin pens are anticipated to present lucrative growth opportunities in the coming years, solidifying the market's trajectory.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Smart Insulin Pens Market Size by Type & CAGR (2025-2032)

• Market Overview
• First Generation Pens
• Second Generation Pens

Global Smart Insulin Pens Market Size by Usability & CAGR (2025-2032)

• Market Overview
• Prefilled
• Reusable

Global Smart Insulin Pens Market Size by Product & CAGR (2025-2032)

• Market Overview
• Smart Insulin Pen
• Adaptors for Conventional Pen

Global Smart Insulin Pens Market Size by Connectivity Type & CAGR (2025-2032)

• Market Overview
• Bluetooth
• USB

Global Smart Insulin Pens Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Smart Insulin Pens Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings

Global Smart Insulin Pens Market Size & CAGR (2025-2032)

• North America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Usability, Product, Connectivity Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Usability, Product, Connectivity Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Companion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digital Medics Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocorp (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• E-Health Technologies (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DarioHealth Corp. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations